Maharashtra's Goods & Services Tax Department has initiated inspection and search proceedings at Lupin's registered office. The pharmaceutical giant stated that these actions will not impact its financials, operations, or other activities. Lupin recently reported strong Q3 FY26 growth, with highest-ever US sales and double-digit growth in India.